NSE: BROOKS - Brooks Laboratories Limited

Yield per half year: -29.8%
Dividend yield: 0.00%

Share chart Brooks Laboratories Limited

en.porti.ru210.00210.00180.00180.00150.00150.00120.00120.0090.0090.0060.0060.00Nov '23Nov '23Dec '23Dec '2320242024Feb '24Feb '24Mar '24Mar '24Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25
Download SVG
Download PNG
Download CSV

About Brooks Laboratories Limited

Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. The company offers liquid and dry powder injection, carbapenem dry powder injectables, tablets, oral suspension, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.


ISIN INE650L01011
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Сайт https://www.brookslabs.net
Цена ао 111.59
Change price per day: 0% (106.36)
Change price per week: -11.73% (120.5)
Change price per month: -0.8853% (107.31)
Change price per 3 month: -39.78% (176.61)
Change price per half year: -29.8% (151.5)
Change price per year: +8.09% (98.4)
Change price per 3 year: +11.61% (95.3)
Change price per 5 year: +226.76% (32.55)
Change price per year to date: -30.84% (153.79)

Underestimation

Title Value Grade
P/S 3.26 5
P/BV 3.92 4
P/E 0 0
EV/EBITDA 62.99 1
Total: 3.75

Efficiency

Title Value Grade
ROA, % -19.59 0
ROE, % -28.08 0
Total: 0.5

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 1.35 8
Total: 9.2

Growth impulse

Title Value Grade
Yield Revenue, % 14.29 3
Yield Ebitda, % -273.22 0
Yield EPS, % -44.2 0
Total: 0.6

Head Job title Payment Year of birth
Mr. Prashant Rathi Chief Financial Officer 1991 (34 years)

Address: India, Mumbai, 201 The Summit Business Bay - open in Google maps, open in Yandex maps
Website: https://www.brookslabs.net